Որոնման արդյունքները - Lothar Roessig
- Ցուցադրվում են 1 - 20 արդյունքները 33
- Գնացեք Հաջորդ էջ
-
1
-
2
Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial Michele Senni, J. López‐Sendón, Alain Cohen‐Solal, Piotr Ponikowski, Richard Nkulikiyinka, Cecilia Freitas, Vanja Vlajnic, Lothar Roessig, Burkert Pieske
Հրապարակվել է 2022Revisão -
3
Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction Frank Kramer, Sebastian Voß, Lothar Roessig, Bernd‐Wolfgang Igl, Javed Butler, Carolyn S.P. Lam, Aldo P. Maggioni, Sanjiv J. Shah, Burkert Pieske
Հրապարակվել է 2020Artigo -
4
Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction Diana Bonderman, Stefano Ghio, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis, Veselin Mitrović, Ronald J. Oudiz, Francis Boateng, Andrea‐Viviana Scalise, Lothar Roessig, Marc J. Semigran
Հրապարակվել է 2013Artigo -
5
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction Stephen J. Greene, Mihai Gheorghiade, Barry A. Borlaug, Burkert Pieske, Muthiah Vaduganathan, John C. Burnett, Lothar Roessig, Johannes‐Peter Stasch, Scott D. Solomon, Walter J. Paulus, Javed Butler
Հրապարակվել է 2013Revisão -
6
Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials Jacob P. Kelly, Robert J. Mentz, Alexandre Mebazaa, Adriaan A Voors, Javed Butler, Lothar Roessig, Mona Fiuzat, Faı̈ez Zannad, Bertram Pitt, Christopher M. O’Connor, Carolyn S.P. Lam
Հրապարակվել է 2015Revisão -
7
Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1) Diana Bonderman, Ingrid Pretsch, Regina Steringer‐Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, Carolyn S.P. Lam, Reiner Frey, Michael Ochan Kilama, Sigrun Unger, Lothar Roessig, Iréne Lang
Հրապարակվել է 2014Artigo -
8
Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure Athanasios Frydas, Daniel A. Morris, Evgeny Belyavskiy, Aravind‐Kumar Radhakrishnan, Martin Kropf, Marijana Tadić, Lothar Roessig, Carolyn S.P. Lam, Sanjiv J. Shah, Scott D. Solomon, Burkert Pieske, Elisabeth Pieske‐Kraigher
Հրապարակվել է 2020Artigo -
9
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRES... Burkert Pieske, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Gerasimos Filippatos, Javed Butler, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Mihai Gheorghiade
Հրապարակվել է 2016Artigo -
10
Rationale and design of the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE</scp> Studies (<scp>SOCRATES</scp>) Burkert Pieske, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Andrea Scalise, Katharina Müller, Lothar Roessig, Mihai Gheorghiade
Հրապարակվել է 2014Artigo -
11
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction Mihai Gheorghiade, Stephen J. Greene, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Katharina Müller, Lothar Roessig, Burkert Pieske
Հրապարակվել է 2015Artigo -
12
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial Carolyn S.P. Lam, Hillary Mulder, Yuri Lopatin, Jose Vazquez-Tanus, D. Siu, Justin A. Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Հրապարակվել է 2021Artigo -
13
Patient‐reported outcomes in the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE patientS</scp> with <scp>PRESERVED</scp> ejection fraction (<scp>S... Gerasimos Filippatos, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Javed Butler, John A. Spertus, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Luke Bamber, Mihai Gheorghiade, Burkert Pieske
Հրապարակվել է 2017Artigo -
14
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator Paul W. Armstrong, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Javed Butler, Adriaan A. Voors, Carolyn S.P. Lam, Piotr Ponikowski, Tracy Temple, Burkert Pieske, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Christopher M. O’Connor
Հրապարակվել է 2017Revisão -
15
Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial Burkert Pieske, Mahesh J. Patel, Cynthia M. Westerhout, Kevin J. Anstrom, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Carolyn S.P. Lam, Piotr Ponikowski, Lothar Roessig, Adriaan A. Voors, Christopher M. O’Connor, Paul W. Armstrong
Հրապարակվել է 2019Artigo -
16
Heart Failure Clinical Trials in East and Southeast Asia Robert J. Mentz, Lothar Roessig, Barry Greenberg, Naoki Sato, Kaori Shinagawa, Daniel Yeo, Bernard W.K. Kwok, Eugenio Reyes, Henry Krum, Burkert Pieske, Stephen J. Greene, Andrew P. Ambrosy, Jacob P. Kelly, Faı̈ez Zannad, Bertram Pitt, Carolyn S.P. Lam
Հրապարակվել է 2016Revisão -
17
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes Justin A. Ezekowitz, Christopher M. O’Connor, Richard W. Troughton, Wendimagegn Alemayehu, Cynthia M. Westerhout, Adriaan A. Voors, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Michele Emdin, Mahesh J. Patel, Burkert Pieske, Lothar Roessig, Adrian F. Hernandez, Paul W. Armstrong
Հրապարակվել է 2020Artigo -
18
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan A. Voors, Gang Jia, Steven E. McNulty, Mahesh J. Patel, Lothar Roessig, Joerg Koglin, Christopher M. O’Connor
Հրապարակվել է 2020Artigo -
19
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> (<scp>Vericiguat</scp> G... Adriaan A. Voors, Hillary Mulder, Eugene B. Reyes, Martín Cowie, Johan Lassus, Adrian F. Hernandez, Justin A. Ezekowitz, Javed Butler, Christopher M. O’Connor, Joerg Koglin, Carolyn S.P. Lam, Burkert Pieske, Lothar Roessig, Piotr Ponikowski, Kevin J. Anstrom, Paul W. Armstrong
Հրապարակվել է 2021Artigo -
20
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial Piotr Ponikowski, Wendimagegn Alemayehu, Ali̇ Oto, M. Cecilia Bahit, Ebrahim Noori, Mahesh J. Patel, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Carolyn S.P. Lam, Christopher M. O’Connor, Burkert Pieske, Lothar Roessig, Adriaan A. Voors, Cynthia M. Westerhout, Paul W. Armstrong
Հրապարակվել է 2021Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Heart failure
Cardiology
Ejection fraction
Pathology
Alternative medicine
Placebo
Clinical trial
Heart failure with preserved ejection fraction
Natriuretic peptide
Randomized controlled trial
Clinical endpoint
Computer science
Confidence interval
Hazard ratio
Intensive care medicine
Pharmacology
Randomization
Atrial fibrillation
Blood pressure
Chemistry
Environmental health
Fraction (chemistry)
Guanylate cyclase
Health care
Myocardial infarction
Nursing
Organic chemistry
Population